Related references
Note: Only part of the references are listed.Loss of PTEN is associated with progression to androgen independence
Jerod Bertram et al.
PROSTATE (2006)
Androgen receptor and prostate apoptosis response factor-4 target the c-FLIP gene to determine survival and apoptosis in the prostate gland
Shen Gao et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2006)
Recent progress in hormonal therapy for advanced prostate cancer
Timothy J. Daskivich et al.
CURRENT OPINION IN UROLOGY (2006)
Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis
M Cully et al.
NATURE REVIEWS CANCER (2006)
c-FLIP inhibits chemotherapy-induced colorectal cancer cell death
DB Longley et al.
ONCOGENE (2006)
Akt-regulated pathways in prostate cancer
PK Majumder et al.
ONCOGENE (2005)
The androgen receptor directly targets the cellular Fas/FasL-associated death domain protein-like inhibitory protein gene to promote the androgen-independent growth of prostate cancer cells
S Gao et al.
MOLECULAR ENDOCRINOLOGY (2005)
The progression of LNCaP human prostate cancer cells to androgen independence involves decreased FOXO3a expression and reduced p27KIP1 promoter transactivation
RL Lynch et al.
MOLECULAR CANCER RESEARCH (2005)
Androgens negatively regulate forkhead transcription factor FKHR (FOXO1) through a proteolytic mechanism in prostate cancer cells
HJ Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Loss of a small region around the PTEN locus is a major chromosome 10 alteration in prostate cancer xenografts and cell lines
KG Hermans et al.
GENES CHROMOSOMES & CANCER (2004)
The Akt-regulated forkhead transcription factor FOXO3a controls endothelial cell viability through modulation of the caspase-8 inhibitor FLIP
C Skurk et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Persistent c-FLIP(L) expression is necessary and sufficient to maintain resistance to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in prostate cancer
XP Zhang et al.
CANCER RESEARCH (2004)
High levels of phosphorylated form of Akt-1 in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence
G Ayala et al.
CLINICAL CANCER RESEARCH (2004)
Increase of AKT/PKB expression correlates with Gleason pattern in human prostate cancer
YD Liao et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Androgen regulation of FLICE-like inhibitory protein gene expression in the rat prostate
KL Nastiuk et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2003)
AKT-independent protection of prostate cancer cells from apoptosis mediated through complex formation between the androgen receptor and FKHR
PF Li et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
TRANSFAC (R): transcriptional regulation, from patterns to profiles
V Matys et al.
NUCLEIC ACIDS RESEARCH (2003)
Stabilization of androgen receptor protein is induced by agonist, not by antagonists
T Furutani et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in normal prostate epithelial cells
A Nesterov et al.
ONCOGENE (2002)
PTEN sensitizes prostate cancer cells to death receptor-mediated and drug-induced apoptosis through a FADD-dependent pathway
XJ Yuan et al.
ONCOGENE (2002)
Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex
A Krueger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Antagonism between PTEN/MMAC1/TEP-1 and androgen receptor in growth and apoptosis of prostatic cancer cells
PF Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Elevated Akt activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis
A Nesterov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells
DJ Panka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
